Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Melissa Mancilla
Observed name:
Mancilla, Melissa
Institution:
Edwards Lifesciences (United States)
Observed institution:
Edwards Lifesciences (United States)
ORCID:
0009-0008-5758-420X
Observed ORCID:
0009-0008-5758-420X
OpenAlex ID:
A5043779460
Inequities in Access to Tricuspid Valve Treatments
2024
·
Colin M. Barker
, Lisa S. Kemp
, et al.
·
JACC Advances
·
4
Understanding Treatment Preferences for Patients with Tricuspid Regurgitation
2024
·
Vijay Iyer
, Nadeen N. Faza
, et al.
·
MDM Policy & Practice
·
2
TCT CONNECT-494 Importance of Symptom and Activity Improvement for Patients With Tricuspid Regurgitation (TR)
2020
·
Ellen Janssen
, Shannon Murphy
, et al.
·
Journal of the American College of Cardiology
·
1
PDF
TCT-720 Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results From the TRISCEND II Trial
2023
·
Michael Brener
, Colin Barker
, et al.
·
Journal of the American College of Cardiology
Abstract 42: Understanding Treatment Preferences For Patients With Tricuspid Regurgitation
2022
·
Melissa Mancilla
, Vijay S Iyer
, et al.
·
Circulation Cardiovascular Quality and Outcomes
Rehabilitacion del paciente con padecimiento vascular cerebral
1981
·
Pedro Fernández de la Vega
, Rogelio Revuelta
, et al.
·
Revista de la Facultad de Medicina UNAM
Rehabilitación del paciente con padecimiento vascular cerebral (PVC) II. Reflecciones sobre algunos problemas
1981
·
Pedro Fernández de la Vega
, Melissa Mancilla
, et al.
Show more works
View as search
Works count:
12
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type